Cadrenal Therapeutics, Inc. (CVKD) Reports Q1 Loss of $2.09

May 8, 2025 8:02 AM

Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) reported Q1 EPS of ($2.09).

For earnings history and earnings-related data on Cadrenal Therapeutics, Inc. (CVKD) click here.